• ZeroStack agreed to sell its 100% stake in Phatebo to New Horizon Pharma for €2.15 million.
• The purchase agreement was signed on November 3, 2026.
• Closing is subject to foreign direct investment clearance in Germany and other closing conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zerostack Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-005837), on November 09, 2026, and is solely responsible for the information contained therein.